To investigate predictors of cardiac morbidity in Valsartan treated high risk hypertensive patients with diabetes, new-onset diabetes and without diabetes : The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial
Latest Information Update: 08 Jun 2021
Price :
$35 *
At a glance
- Drugs Valsartan (Primary) ; Amlodipine
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms VALUE
- 14 Apr 2021 Results of post hoc analysis of value trial assessing the risk of cardiovascular events in mostly elderly high-risk hypertensive patients with type-2 DM participating in the valsartan antihypertensive long-term use evaluation trial, presented at the Joint Meeting of the European Society of Hypertension and International Society of Hypertension
- 01 Apr 2019 Results published in the Blood Pressure
- 11 Jun 2018 Results assessing blood pressure variability (n=14996) presented at the 28th European Meeting on Hypertension and Cardiovascular Protection.